NCT01908972View on ClinicalTrials.gov

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Hemangioma
Interventions
DRUG

Prednisolone

2mg/kg/day for 16weeks

DRUG

Propranolol

2mg/kg/day for 16weeks

Trial Locations (1)

110-744

Seould National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01908972 - The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | Biotech Hunter | Biotech Hunter